nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes
|
Gergis, Usama |
|
2019 |
25 |
3 |
p. 466-473 |
artikel |
2 |
Allogeneic Hematopoietic Cell Transplantation in Patients Aged 50Years or Older with Severe Aplastic Anemia
|
Rice, Carmel |
|
2019 |
25 |
3 |
p. 488-495 |
artikel |
3 |
Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia
|
Veltri, Lauren |
|
2019 |
25 |
3 |
p. 505-514 |
artikel |
4 |
ASBMT Notes
|
|
|
2019 |
25 |
3 |
p. 623 |
artikel |
5 |
ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation
|
Sauter, Craig S. |
|
2019 |
25 |
3 |
p. e86-e88 |
artikel |
6 |
Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis
|
Sidiqi, M. Hasib |
|
2019 |
25 |
3 |
p. e108-e111 |
artikel |
7 |
Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells
|
Stokes, Jessica |
|
2019 |
25 |
3 |
p. 405-416 |
artikel |
8 |
CD3+/CD19+ Depleted Matched and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplant with Targeted T Cell Addback Is Associated with Excellent Outcomes in Pediatric Patients with Nonmalignant Hematologic Disorders
|
Oved, Joseph H. |
|
2019 |
25 |
3 |
p. 549-555 |
artikel |
9 |
Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
|
Takamatsu, Hiroyuki |
|
2019 |
25 |
3 |
p. 474-479 |
artikel |
10 |
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Transplantation and Cellular Therapy
|
Kansagra, Ankit J. |
|
2019 |
25 |
3 |
p. e76-e85 |
artikel |
11 |
Comparison of HLA Allele Mismatch and Antigen Mismatch in Unrelated Bone Marrow Transplantation in Patients with Leukemia
|
Atsuta, Yoshiko |
|
2019 |
25 |
3 |
p. 436-442 |
artikel |
12 |
Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis
|
Rozmus, Jacob |
|
2019 |
25 |
3 |
p. 451-458 |
artikel |
13 |
Consider Allogeneic Bone Marrow Transplantation for Older, FitPatients with Aplastic Anemia
|
Georges, George E. |
|
2019 |
25 |
3 |
p. e69-e70 |
artikel |
14 |
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution
|
Melendez-Munoz, Ricardo |
|
2019 |
25 |
3 |
p. 577-586 |
artikel |
15 |
Editorial Board
|
|
|
2019 |
25 |
3 |
p. A2 |
artikel |
16 |
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation
|
Brunstein, Claudio G. |
|
2019 |
25 |
3 |
p. 480-487 |
artikel |
17 |
Effects of Low-Dose Glucocorticoid Prophylaxis on Chronic Graft-versus-Host Disease and Graft-versus-Host Disease–Free, Relapse-Free Survival after Haploidentical Transplantation: Long-Term Follow-Up of a Controlled, Randomized Open-Label Trial
|
Chang, Ying-Jun |
|
2019 |
25 |
3 |
p. 529-537 |
artikel |
18 |
Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America
|
Khera, Nandita |
|
2019 |
25 |
3 |
p. 599-605 |
artikel |
19 |
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial
|
Reshef, Ran |
|
2019 |
25 |
3 |
p. 515-521 |
artikel |
20 |
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation
|
Raj, Kavita |
|
2019 |
25 |
3 |
p. 522-528 |
artikel |
21 |
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients
|
Bhatt, Sima T. |
|
2019 |
25 |
3 |
p. 556-561 |
artikel |
22 |
Impact of Body Mass Index on Outcomes of Hematopoietic Stem Cell Transplantation in Adults
|
Doney, Kristine |
|
2019 |
25 |
3 |
p. 613-620 |
artikel |
23 |
Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation
|
Kamboj, Mini |
|
2019 |
25 |
3 |
p. 594-598 |
artikel |
24 |
Letter to the Editor Regarding “Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis”
|
Nikpour, Mandana |
|
2019 |
25 |
3 |
p. e112-e113 |
artikel |
25 |
Lymphocyte Area Under the Curve as a Predictive Factor for Viral Infection after Allogenic Hematopoietic Stem Cell Transplantation
|
Watanabe, Mizuki |
|
2019 |
25 |
3 |
p. 587-593 |
artikel |
26 |
Masthead (Purpose and Scope)
|
|
|
2019 |
25 |
3 |
p. A1 |
artikel |
27 |
Mononuclear Cell Telomere Attrition Is Associated with Overall Survival after Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies
|
Helby, Jens |
|
2019 |
25 |
3 |
p. 496-504 |
artikel |
28 |
Obituary - Dr. Hans August Messner
|
Huebsch, Lothar |
|
2019 |
25 |
3 |
p. 621-622 |
artikel |
29 |
Officers and Directors of ASBMT
|
|
|
2019 |
25 |
3 |
p. A4 |
artikel |
30 |
Peripheral Immunotype Correlates with Minimal Residual Disease Status and Is Modulated by Immunomodulatory Drugs in Multiple Myeloma
|
Bhutani, Manisha |
|
2019 |
25 |
3 |
p. 459-465 |
artikel |
31 |
Quantitative Assessment of T Cell Clonotypes in Human Acute Graft-versus-Host Disease Tissues
|
Koyama, Daisuke |
|
2019 |
25 |
3 |
p. 417-423 |
artikel |
32 |
Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study
|
Mayor, Neema P. |
|
2019 |
25 |
3 |
p. 443-450 |
artikel |
33 |
Reply: Letter to the Editor Regarding “Autologous Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis”
|
Shouval, Roni |
|
2019 |
25 |
3 |
p. e114-e115 |
artikel |
34 |
Role of Regulatory T Cells in Noninherited Maternal Antigen-Related Tolerance in Cord Blood: An in Vitro Study
|
Kwok, Janette |
|
2019 |
25 |
3 |
p. 424-435 |
artikel |
35 |
Summary of the Second Annual BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
|
Holstein, Sarah A. |
|
2019 |
25 |
3 |
p. e89-e97 |
artikel |
36 |
Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation
|
Raymond, Gerald V. |
|
2019 |
25 |
3 |
p. 538-548 |
artikel |
37 |
Table of Contents
|
|
|
2019 |
25 |
3 |
p. A5-A11 |
artikel |
38 |
Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation
|
Denzen, Ellen M. |
|
2019 |
25 |
3 |
p. 562-569 |
artikel |
39 |
The Art of Transplantation: Conditioning Intensity for Allogeneic Hematopoietic Stem Cell Transplantation
|
Ragon, Brittany Knick |
|
2019 |
25 |
3 |
p. e71-e72 |
artikel |
40 |
The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation
|
Solh, Melhem M. |
|
2019 |
25 |
3 |
p. 606-612 |
artikel |
41 |
The Future of Chimeric Antigen Receptor T Cell Therapy for the Treatment of Multiple Myeloma
|
Cornell, R. Frank |
|
2019 |
25 |
3 |
p. e73-e75 |
artikel |
42 |
The Role of Salvage Second Autologous Hematopoietic Cell Transplantation in Relapsed Multiple Myeloma
|
Hagen, Patrick Alan |
|
2019 |
25 |
3 |
p. e98-e107 |
artikel |
43 |
Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal
|
Li, Ang |
|
2019 |
25 |
3 |
p. 570-576 |
artikel |